Dishman Carbogen Amcis Share Price
09 Oct, 2026 3:52 PM (IST)
Dishman Carbogen Amcis Performance
- Today's Low
- ₹145
- Today's High
- ₹152
- 52 Week Low
- ₹129
- 52 Week High
- ₹303
- Open Price₹148
- Previous Close₹147
- Volume140,170
- 50 DMA₹169.50
- 100 DMA₹177.00
- 200 DMA₹189.80
Dishman Carbogen Amcis Chart
Investment Returns
- Over 1 Month -12.26%
- Over 3 Month -22.38%
- Over 6 Month -5.53%
- Over 1 Year -47.2%
Smart Investing Starts Here Start SIP with Dishman Carbogen Amcis for Steady Growth!
Dishman Carbogen Amcis Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 145.2
- PEG Ratio
- -1.7
- Market Cap Cr
- 2,347
- P/B Ratio
- 0.4
- Average True Range
- 6.3
- EPS
- 1
- Dividend Yield
- 0
- MACD Signal
- -6.7
- RSI
- 32.99
- MFI
- 29.63
Latest Stock News Updates
Please find enclosed herewith Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September, 2026.
- BSE India
- 2 days 3 hours ago
We would like to inform you that the Board of Directors of the Company has at its meeting held today, i.e., Wednesday, October 7, 2026 which was commenced at 13:30 p.m. and concluded at 14:10 p.m., approved; (I) issuance of senior, secured, rated, listed, transferable, redeemable, taxable non-convertible debentures aggregating up to Rs. 38 crores (ii) modification/amendment in security in respect of the company''s tranche ii of 1,500 senior, secured, rated, listed, transferable, redeemable, taxable non- convertible debentures of face value of ?1,00,000/- each, aggregating to Rs.15 crore, allotted on september 28, 2026 having scrip code 978230.
- BSE India
- 3 days 5 hours ago
Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 ,inter alia, to consider and approve a) the proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement, subject to such regulatory or statutory approvals as may be required; b) the proposal of modification/change in security in respect of the Company''s Tranche II of 1,500 Senior, Secured, Rated, Listed, Transferable, Redeemable, Taxable Non- Convertible Debentures of face value of ?1,00,000/- each, aggregating to ?15 Crore, allotted on September 28, 2026 having Scrip Code 978230.
- BSE India
- 1 week 1 day ago
Dishman Carbogen Amcis Financials
Dishman Carbogen Amcis Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹160.40
- 50 Day
- ₹169.50
- 100 Day
- ₹177.00
- 200 Day
- ₹189.80
Resistance and Support
- R3 158.90
- R2 155.40
- R1 152.50
- S1 146.10
- S2 142.50
- S3 139.70
Dishman Carbogen Amcis Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-10-07 | Proposal of fund raising | Inter alia, a) the proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement. |
| 2026-08-14 | Quarterly Results | |
| 2026-08-12 | Proposal Of Fund Raising | |
| 2026-05-19 | Audited Results | |
| 2026-03-18 | To consider Fund Raising |
About Dishman Carbogen Amcis
Dishman Carbogen Amcis is engaged in Contract Development and Manufacturing Organization (CDMO) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins& chemicals and disinfectants. View More- NSE Symbol
- DCAL
- BSE Symbol
- 540701
- ISIN
- INE385W01011
Similar Stocks to Dishman Carbogen Amcis
Popular Stocks
Dishman Carbogen Amcis FAQs
Dishman Carbogen Amcis share price is ₹149 As on 10 October, 2026 | 19:25
The Market Cap of Dishman Carbogen Amcis is ₹2346.7 Cr As on 10 October, 2026 | 19:25
The P/E ratio of Dishman Carbogen Amcis is 145.2 As on 10 October, 2026 | 19:25
The PB ratio of Dishman Carbogen Amcis is 0.4 As on 10 October, 2026 | 19:25
The 52 week High & Low of Dishman Carbogen Amcis is ₹303/₹128.5 respectively As on 10 October, 2026 | 19:25
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.